Skip to Content
Merck
  • Viral competition assay to assess the role of HIV-1 proteins in immune evasion.

Viral competition assay to assess the role of HIV-1 proteins in immune evasion.

STAR protocols (2023-03-01)
Gabriel Duette, Samantha Cronin, Anthony D Kelleher, Sarah Palmer
ABSTRACT

CD8+ T lymphocytes can recognize and eliminate cells infected by viruses. However, the human immunodeficiency virus (HIV-1) has developed mechanisms to evade CD8+ T-cell-mediated clearance. Here, we describe a protocol to assess the role of the HIV-1 protein Nef in immune evasion. The viral competition assay reveals the preferential killing of HIV-1-infected cells unable to express Nef. This methodology can be extended to study HIV-1 proteins involved in immune evasion and viral variants encoding cytotoxic T lymphocyte escape mutations. For complete details on the use and execution of this protocol, please refer to Duette et al. (2022).1.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Raltegravir potassium